Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mangalika Warthaka

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
ACS Chemical Biology|December 23, 2006
Phosphopeptide modification and enrichment by oxidation-reduction condensationMangalika Warthaka, Paulina Karwowska-Desaulniers, Mary Kay H Pflum
Current Protocols in Molecular Biology|June 29, 2010
Fluorescent peptide assays for protein kinasesAshwini K Devkota, Tamer S Kaoud, Mangalika Warthaka, et al.
Biochemistry|September 30, 2011
Examining docking interactions on ERK2 with modular peptide substratesSunbae Lee, Mangalika Warthaka, Chunli Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2Andrea Piserchio, Mangalika Warthaka, Tamer S Kaoud, et al.
Current Protocols|March 5, 2024
Steady State and Time-Dependent Fluorescent Peptide Assays for Protein KinasesRae M Sammons, Ashwini K Devkota, Tamer S Kaoud, et al.
Plos One|April 16, 2011
A model of a MAPK•substrate complex in an active conformation: a computational and experimental approachSunbae Lee, Mangalika Warthaka, Chunli Yan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2013
Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpressionPiyanuch Wonganan, Dharmika S P Lansakara-P, Saijie Zhu, et al.
Biochemistry|April 1, 2011
Solution NMR insights into docking interactions involving inactive ERK2Andrea Piserchio, Mangalika Warthaka, Ashwini K Devkota, et al.
Journal of Biomolecular Screening|October 1, 2013
High-throughput screens for eEF-2 kinaseAshwini K Devkota, Mangalika Warthaka, Ramakrishna Edupuganti, et al.
Biochemistry|February 23, 2012
Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifactAshwini K Devkota, Clint D J Tavares, Mangalika Warthaka, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
ACS Chemical Biology|December 23, 2006
Phosphopeptide modification and enrichment by oxidation-reduction condensationMangalika Warthaka, Paulina Karwowska-Desaulniers, Mary Kay H Pflum
Current Protocols in Molecular Biology|June 29, 2010
Fluorescent peptide assays for protein kinasesAshwini K Devkota, Tamer S Kaoud, Mangalika Warthaka, et al.
Biochemistry|September 30, 2011
Examining docking interactions on ERK2 with modular peptide substratesSunbae Lee, Mangalika Warthaka, Chunli Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2Andrea Piserchio, Mangalika Warthaka, Tamer S Kaoud, et al.
Current Protocols|March 5, 2024
Steady State and Time-Dependent Fluorescent Peptide Assays for Protein KinasesRae M Sammons, Ashwini K Devkota, Tamer S Kaoud, et al.
Plos One|April 16, 2011
A model of a MAPK•substrate complex in an active conformation: a computational and experimental approachSunbae Lee, Mangalika Warthaka, Chunli Yan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2013
Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpressionPiyanuch Wonganan, Dharmika S P Lansakara-P, Saijie Zhu, et al.
Biochemistry|April 1, 2011
Solution NMR insights into docking interactions involving inactive ERK2Andrea Piserchio, Mangalika Warthaka, Ashwini K Devkota, et al.
Journal of Biomolecular Screening|October 1, 2013
High-throughput screens for eEF-2 kinaseAshwini K Devkota, Mangalika Warthaka, Ramakrishna Edupuganti, et al.
Biochemistry|February 23, 2012
Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifactAshwini K Devkota, Clint D J Tavares, Mangalika Warthaka, et al.
Pageof 2